Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198

Psychopharmacology

Volumn 161, Issue 2, 2002, Pages 113-119

  Ciccocioppo, Roberto ^a   Biondini, Michela ^a   Antonelli, Lorena ^a   Wichmann, Juergen ^b   Jenck, François ^b   Massi, Maurizio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Anorexia; CRF; Nociceptin orphanin FQ; ORL1 receptor; Ro 64 6198; Stress

Indexed keywords

8 (2,3,3,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4,5]DECAN 4 ONE; 8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; BENZODIAZEPINE DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DIAZEPAM; LIPOPOLYSACCHARIDE; NOCICEPTIN; NOCICEPTIN RECEPTOR AGONIST; POLY(METHYL METHACRYLATE); UNCLASSIFIED DRUG;

ANIMAL MODEL; ANOREXIA; ARTICLE; CAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; DRUG SYNTHESIS; ESCHERICHIA COLI; EVALUATION; FEEDING; FOOD DEPRIVATION; FOOD INTAKE; HUMAN; HYPOPHAGIA; IMMOBILIZATION STRESS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION;

ANIMALS; ANOREXIA; ANTI-ANXIETY AGENTS; CORTICOTROPIN-RELEASING HORMONE; IMIDAZOLES; MALE; OPIOID PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SPIRO COMPOUNDS; STRESS;

EID: 0036250290     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1020-7     Document Type: Article

References (49)

1. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress
2. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type
3. Pharmacology of nociceptin and its receptor: A novel therapeutic target
4. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family
5. Effect of nociceptin on alcohol intake in alcohol-preferring rats
6. Nociceptin/orphanin FQ and drugs of abuse
7. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats
8. Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice
9. Effects of chlordiazepoxide and diazepam on feeding performance in a food-preference test
10. A microgram dose of diazepam produces specific inhibition of ambulation in the rat
11. Orphanin FQ/nociceptin: A role in pain and analgesia, but so much more
12. Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders
13. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ
14. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis
15. 3H]nociceptin binding sites in the rat brain
16. cDNA cloning and regional distribution of a novel member of the opioid receptor family
17. Corticotropin-releasing factor and anorexia nervosa: Reactions of the hypothalamus-pituitary-adrenal axis to neurotropic stress
18. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
19. Opiate modulating properties of nociceptin/orphanin FQ
20. Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats
21. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats
22. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
23. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat
24. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
25. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice
26. Verapamil and indo-methacin attenuate endotoxin-induced anorexia
27. Effect of centrally administered corticotropin releasing factor (CRF) on multiple feeding paradigms
28. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats
29. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor
30. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
31. Orphanin FQ is a functional antiopioid peptide
32. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization
33. Neuropeptide regulation of appetite and weight
34. Corticotrophin releasing factor, grooming and ingestive behavior
35. Orphanin FQ/nociceptin blocks acquisition of morphine place preference
36. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with 125I-[(14)Tyr]-orphanin FQ binding
37. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat
38. Pharmacological characterization of the nociceptin receptor mediating hyperphagia: Identification of a selective antagonist
39. The hyperphagic effect of nociceptin/orphanin FQ in rats
40. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats
41. Orphanin FQ: A neuropeptide that activates an opioid-like G protein-coupled receptor
42. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats
43. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia
44. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide
45. Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake
46. CRF-deficient mice respond like wild-type mice to hypophagic stimuli
47. Synthesis of (1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza- spiro[4.5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties
48. Effects of a novel corticotropin-releasing-hormone receptor type 1 antagonist on human adrenal function